Detalhe da pesquisa
1.
Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
Ann Surg Oncol
; 25(10): 2948-2952, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987599
2.
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?
Oncology (Williston Park)
; 30(2): 148-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892151
3.
Integrating Breast Cancer Risk Management into Primary Care.
Am Fam Physician
; 101(6): 330-331, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32163248
4.
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.
JAMA Oncol
; 10(2): 227-235, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991778
5.
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.
Clin Cancer Res
; 30(10): 2160-2169, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466643
6.
Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: One size does not fit all.
Am J Surg
; 225(1): 21-25, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180303
7.
Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy.
Healthcare (Basel)
; 11(3)2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36766992
8.
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease.
NPJ Breast Cancer
; 9(1): 10, 2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878909
9.
Diagnostic and treatment considerations when newly diagnosed breast cancer coincides with pregnancy: a case report and review of literature.
J Natl Compr Canc Netw
; 10(2): 145-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308513
10.
Everolimus for Estrogen Receptor-negative Breast Cancer Prevention: A Journey Begun?
Cancer Prev Res (Phila)
; 15(12): 787-789, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453053
11.
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer.
NPJ Breast Cancer
; 8(1): 80, 2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817765
12.
Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors.
Cancers (Basel)
; 13(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638355
13.
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.
Clin Cancer Res
; 27(14): 3896-3904, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602685
14.
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP).
Clin Cancer Res
; 27(4): 975-982, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208340
15.
Effect of Bazedoxifene and Conjugated Estrogen (Duavee) on Breast Cancer Risk Biomarkers in High-Risk Women: A Pilot Study.
Cancer Prev Res (Phila)
; 12(10): 711-720, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420361
16.
Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
Clin Breast Cancer
; 17(4): e185-e189, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185739